Lanadelumab shown to significantly reduce hereditary angioedema attacks in Japanese patients

Lanadelumab shown to significantly reduce hereditary angioedema attacks in Japanese patients|Image Credit: © Africa Studio – ©Africa Studio – stock.adobe.com.

Lanadelumab leads to a considerable decrease in regularity of hereditary angioedema (HAE) attacks, according to current searchings for, and also the therapy is well-tolerated as a prophylactic treatment. ¹

These research results originated from brand-new study from Japan in which private investigators took a look at the effectiveness and also the safety and security of lanadelumab as a way to protect against HAE attacks in patients particularly from Japan.

This study adheres to the current sign of lanadelumab sign in the United States, throughout which the therapy was increased to consist of pediatric people in the age series of ≥ 2 years in February of 2023. ² The research was authored by Ming Yu, MD, PhD, from the Takeda Development Center Americas, Inc, in Lexington, Massachusetts.

“To bridge …